Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

3.1K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.1K
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

4.4K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.4K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

6.7K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
6.7K
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

534
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
534

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developing a web-based dashboard for adaptive radiotherapy workflows.

Journal of applied clinical medical physics·2026
Same author

Hippocampal volume from T1 MRI as an atrophy biomarker: automated calculation and Scheltens' scale correlation.

Magma (New York, N.Y.)·2026
Same author

The Effect of Timing of Sports Massage on 60-m Sprint Performance in Competitive Athletes.

International journal of therapeutic massage & bodywork·2025
Same author

NTCP model guided whole brain radiation re-planning to reduce risk of acute xerostomia and dry eye.

Journal of applied clinical medical physics·2025
Same author

In Reply to Chen.

International journal of radiation oncology, biology, physics·2025
Same author

Use of NTCP metrics to identify unbalanced levels of dose trade-off between left lung and heart in lung cancer radiotherapy.

Journal of applied clinical medical physics·2025
Same journal

A case study of inhale and exhale split-course VMAT treatment to minimize dose to ribs.

Medical dosimetry : official journal of the American Association of Medical Dosimetrists·2026
Same journal

Prospective clinical implementation of the robust optimization planning technique in long-course photon radiotherapy treatment for lung cancer.

Medical dosimetry : official journal of the American Association of Medical Dosimetrists·2026
Same journal

Dosimetric comparison of target coverage, dose gradient, and low-dose bath in left-sided accelerated partial breast irradiation: CyberKnife versus conventional linac-based noncoplanar VMAT and 3D-CRT.

Medical dosimetry : official journal of the American Association of Medical Dosimetrists·2026
Same journal

Cross-prescription validation of knowledge-based planning in prostate VMAT using a structured validation framework.

Medical dosimetry : official journal of the American Association of Medical Dosimetrists·2026
Same journal

Dosimetric evaluation of beam block techniques in helical tomotherapy for extranodal nasal-type NK/T-cell lymphoma.

Medical dosimetry : official journal of the American Association of Medical Dosimetrists·2026
Same journal

The dosimetric impact to bladder utilizing the Varian Edge linear accelerator for prostate stereotactic body radiation therapy.

Medical dosimetry : official journal of the American Association of Medical Dosimetrists·2026
See all related articles

Related Experiment Video

Updated: Jun 25, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

Dose-response modeling and treatment plan assessment with a python software toolkit.

Athanasios Tzikas1, Eleftherios Lavdas1, Dimitrios Kechagias1

  • 1University of West Attica, Department of Biomedical Sciences, Athens, Greece.

Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists
|May 23, 2024
PubMed
Summary
This summary is machine-generated.

This software calculates tumor control and normal tissue complication probabilities using patient data and dose-response models. It optimizes treatment plans for better outcomes in radiation oncology.

Keywords:
Dose-response relationsModel parameter determinationNormal Tissue Complication Probability (NTCP) modelRadiobiological softwareTreatment plan assessmentTumor Control probability (TCP) model

More Related Videos

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.8K
Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.7K

Related Experiment Videos

Last Updated: Jun 25, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.8K
Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.7K

Area of Science:

  • Radiation Oncology
  • Medical Physics
  • Computational Biology

Background:

  • Accurate prediction of tumor control and normal tissue complication probabilities is crucial for optimizing radiation therapy.
  • Existing methods for dose-response assessment can be computationally intensive and may lack comprehensive analysis tools.
  • There is a need for integrated software to derive and apply radiobiological models efficiently.

Purpose of the Study:

  • To develop a Python-based software assistant for calculating dose-response relationships in tumors and normal tissues.
  • To enable clinical assessment of pre-determined radiobiological values and optimize radiation dose prescriptions.
  • To provide tools for treatment plan assessment, comparison, and optimization studies.

Main Methods:

  • The software utilizes patient dose-volume histograms (DVHs) and clinical outcomes to derive parameters for tumor control probability (TCP) and normal tissue complication probability (NTCP) models.
  • It incorporates components for dose-response relation derivation and treatment plan assessment, including calculations of generalized equivalent uniform doses (gEUD) and biologically effective uniform doses (D‾‾).
  • Statistical analyses such as odds ratio (OR) and area under the curve (AUC) are performed for model evaluation and discrimination capacity assessment.

Main Results:

  • The software can rapidly calculate gEUD and D‾‾ for various radiobiological models (LKB, PV, RS).
  • It generates dose-response curves with confidence intervals, plots patient data, and evaluates model goodness-of-fit.
  • Treatment plan assessment includes calculation of TCP, NTCP, probabilities of benefit (PB), injury (PI), and complication-free tumor control (P+), with associated dose-response plots.

Conclusions:

  • The developed software provides an efficient and comprehensive platform for radiobiological modeling and treatment plan optimization.
  • It facilitates the derivation and application of TCP and NTCP models, aiding in clinical decision-making.
  • The tool is valuable for researchers and clinicians conducting studies in radiation oncology dose-response assessment.